National Cancer Institute - NCI Division of Cancer Treatment and ...

More documents

Recommendations

Info

R A D I A T I O N M ER E T S ET AH RE CDH CPT RD OSG TR A FMF Division of Cancer Treatment and Diagnosis Office of the Director Dr. James Doroshow Division Director Dr. Joseph Tomaszewski Deputy Division Director Ms. Lynn Cave Scientific Information Analyst Ms. Margaret Gartland Secretary Dr. Anthony Murgo Medical Officer Dr. Oxana Pickeral Strategic Advisor [Contractor] Ms. Sonjia Shorts Secretary Biometric Research Branch Dr. Richard Simon Branch Chief Dr. Paul Albert Mathematical Statistician Dr. Lori Dodd Mathematical Statistician Dr. Boris Freidlin Mathematical Statistician Dr. Sally Hunsberger Mathematical Statistician Dr. Edward Korn Mathematical Statistician Dr. Lisa McShane Mathematical Statistician Dr. Lawrence Rubinstein Mathematical Statistician Dr. Joanna Shih Mathematical Statistician Dr. George Wright Mathematical Statistician Dr. Yingdong Zhao Biologist Cancer Diagnosis Program Office of the Associate Director Dr. Sheila Taube Associate Director Dr. Kevin Dobbin Mathematical Statistician Ms. Wendy Fredericks Biologist Dr. Rebecca Huppi Cancer Diagnosis Program Specialist Diagnostic Biomarkers and Technology Branch Dr. James Jacobson Branch Chief Dr. Avraham Rasooly Microbiologist Diagnostics Evaluation Branch Dr. J. Milburn Jessup Branch Chief Dr. Tracy Lively Associate Chief Dr. Magdalena Thurin Health Scientist Administrator Dr. James Tricoli Health Scientist Administrator Resources Development Branch Dr. Yaffa Rubinstein Health Scientist Administrator D C T D R O S T E R ■ 131
Cancer Imaging Program 132 ■ P R O G R A M A C C O M P L I S H M E N T S 2 0 0 6 Office of the Associate Director Dr. Daniel Sullivan Associate Director Ms. Nancy Pursell Administrative Program Specialist Dr. Gary Dorfman Intermanagement Personnel Agreement Dr. Gary Kelloff Expert Dr. Lalitha Shankar Senior Disciplinary Scientist Dr. Denise Aberle Intermanagement Personnel Agreement Dr. Bonnie Fiedorek Sloane Intermanagement Personnel Agreement Dr. Paula Jacobs Regulatory Affairs Director [Contractor] Ms. Lavonia Logan Diagnostic Imaging Branch Contractor Dr. Conrade Carl Jaffe Branch Chief Ms. Barbara Galen Nurse Consultant Image-Guided Intervention Branch Vacant Program Director Dr. Keyvan Farahani Expert Imaging Technology Development Branch Dr. Laurence Clarke Branch Chief Dr. Houston Baker Health Scientist Administrator Dr. Guoying Liu Health Scientist Administrator Dr. Robert Nordstrom Molecular Imaging Branch Health Scientist Administrator Dr. James Tatum Branch Chief Dr. Barbara Croft Program Director Dr. Anne Menkens Health Scientist Administrator
Page 1 and 2:
National Cancer Institute U.S. DEPA
Page 3 and 4:
ii ■ P R O G R A M A C C O M P L
Page 5 and 6:
Clinical trials performed using an
Page 7 and 8:
Dr. James H. Doroshow, Director Jam
Page 9 and 10:
Cancer Diagnosis Program Dr. Sheila
Page 11 and 12:
DCTD Research Grants 6 ■ P R O G
Page 13 and 14:
disease-specific steering committee
Page 15 and 16:
■ The DCTD Developmental Therapeu
Page 17 and 18:
P A R T N E R S H I P S A N D C O L
Page 19 and 20:
laboratories. Dr. Kevin Dobbin, BRB
Page 21 and 22:
■ Gene expression patterns and pr
Page 23 and 24:
Simon R. DNA microarrays for diagno
Page 25 and 26:
Microarray Myths and Truths Myths
Page 27 and 28:
target, is sensitive to the agent.
Page 29 and 30:
O T H E R B I O S T A T I S T I C A
Page 31 and 32:
almost inevitably leads to an invas
Page 33 and 34:
Software and Technical Report Archi
Page 35 and 36:
Biomarker Development Process Marke
Page 37 and 38:
Strategic Partnering to Evaluate Ca
Page 39 and 40:
C U R R E N T F U N D I N G O P P O
Page 41 and 42:
P A R T N E R S H I P S A N D C O L
Page 43 and 44:
several types of cancer TMAs have b
Page 45 and 46:
Courtesy of NCI Visuals Online, Bil
Page 47 and 48:
■ Cooperative Human Tissue Networ
Page 49 and 50:
Progress in many areas of cancer re
Page 51 and 52:
Diagnostic Imaging Program in 1996,
Page 53 and 54:
NCI Visuals Online, Terese Winslow,
Page 55 and 56:
■ Support development and deliver
Page 57 and 58:
Small Animal Imaging Resource Progr
Page 59 and 60:
C U R R E N T F U N D I N G O P P O
Page 61 and 62:
Quick-Trials for Imaging and Image-
Page 63 and 64:
Association of American Cancer Inst
Page 65 and 66:
Food and Drug Administration and Ce
Page 67 and 68:
Dr. Edward A. Neuwelt, Oregon Healt
Page 69 and 70:
Virtual Colonoscopy Training Collec
Page 71 and 72:
Not only does CTEP identify promisi
Page 73 and 74:
The Clinical Trials Cooperative Gro
Page 75 and 76:
of pediatric cancers and therapeuti
Page 77 and 78:
the front line treatment of chronic
Page 79 and 80:
Quick-Trials for Novel Cancer Thera
Page 81 and 82:
Industry Collaborators Agent Name 7
Page 83 and 84:
Industry Collaborators Agent Name 7
Page 85 and 86: NCI Visuals Online, George McGregor
Page 87 and 88: provided for use in this clinical t
Page 89 and 90: with or without bevacizumab (NSC #
Page 91 and 92: Oxaliplatin-Based Regimen Permits S
Page 93 and 94: egular checkups to look for lymph-n
Page 95 and 96: NCI Visuals Online. Human lymphoma
Page 97 and 98: T O O L S , P R O D U C T S , A N D
Page 99 and 100: ■ Clinical Trials Monitoring Bran
Page 101 and 102: DTP’s staff and administered gran
Page 103 and 104: therapeutics. Proposed exploratory
Page 105 and 106: M A J O R O N G O I N G I N I T I A
Page 107 and 108: National Cancer Institute. discover
Page 109 and 110: C U R R E N T F U N D I N G O P P O
Page 111 and 112: DTP oversees animal-production faci
Page 113 and 114: disease can require considerable in
Page 115 and 116: National Cancer Institute. commerci
Page 117 and 118: The Type 1 Diabetes Rapid Access to
Page 119 and 120: H I S T O R Y - M A R K I N G E V E
Page 121 and 122: With this approach, patients are no
Page 123 and 124: This included a camptothecin deriva
Page 125 and 126: RRP supports research involving a v
Page 127 and 128: Laredo Medical Center, Laredo, TX h
Page 129 and 130: With TELESYNERGY® as a link, healt
Page 131 and 132: Radiation Bioterrorism Research and
Page 133 and 134: Enhanced Radiosensitivity The Molec
Page 135: M E E T I N G S A N D W O R K S H O
Page 139 and 140: Cancer Therapy Evaluation Program,
Page 141 and 142: Developmental Therapeutics Program,
Page 143 and 144: Developmental Therapeutics Program,
show all

National Cancer Institute - NCI Division of Cancer Treatment and ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?